FOX8 Cleveland

Transposon Receives Investment from the Alzheimer's Drug Discovery Foundation to Support Advancement of TPN-101 for the Treatment of Alzheimer's Disease

Building on the positive results of Phase 2 clinical trials in PSP and ALS, Transposon plans to initiate a Phase 2 clinical trial of TPN-101 for the treatment of Alzheimer's disease in Q4 2025 ...
Medscape

Prevention of Intravenous Drug Incompatibilities in an Intensive Care Unit

After approval of the study protocol by the ethics committee of the Medical Faculty of the University of Heidelberg, we evaluated parenteral drug treatment in patients admitted to a 12-bed ICU in a ...

CorMedix: Strong Buy After Strong Developments And A Strategy Before Earnings

CorMedix acquires Melinta, diversifies products, and raises 2025 revenue outlook to $375M. Read here for more details on CRMD ...
Columbus Dispatch

Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication ...

Additional update: Results of ongoing investigator-initiated proof-of-concept trial in United Arab Emirates (UAE) demonstrate further reduction of total parenteral support (PS) (comprised of total ...